Recent advances in our understanding of neurodegeneration
The DOI matches its Crossref record; 617 of the 618 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are featured by progressive dysfunction and death of cells in selected areas in the nervous system, determining clinical presentation. Neuronal loss is associated with conformational changes in proteins that result in extra- and intra-cellular accumulation of misfolded proteins, representing the hallmarks of many neurodegenerative disorders, summarized as proteinopathies. Intermediate forms such as oligomers and protofibrils are thought to have cytotoxic effects to neurons. Major basic processes, caused by genetic, environmental, and endogenous factors, in addition to abnormal protein dynamics with defective degradation due to deficiency of the ubiquitin-proteosomal-autophagy system, include oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunction, disruption of neuronal Golgi apparatus and transport, molecular chaperones, neurotrophins and "neuroinflammatory" processes. These mechanisms are interrelated in vicious circles finally leading to programmed cell death. A common feature of these conditions is a long run until sufficient protein accumulates, followed by a cascade of symptoms over many years with increasing disability leading to death. This provides a wide therapeutic window, especially in groups at risk identified early and preclinical diagnosis becomes feasible. Neurodegenerative disorders are classified according to known genetic mechanisms or to the major components of protein deposits. Although this has been a productive paradigm for the development of diagnostic consensus criteria, recent molecular biologic and genetic approaches have revealed that there are both overlap and intraindividual diversities between different phenotypes, related to synergistic mechanisms between major pathologic proteins (beta-amyloid, tau, alpha-synuclein, TDP-43), suggesting common pathogenic mechanisms. The nature, time course, and molecular causes of cell degeneration and demise, and the role of various pathogenic factors are a matter of considerable debate, but recent studies have provided insight into the basic processes in neurodegeneration and the roles of cell death programs common to this complex group of disorders, offering new ways for future prevention and treatment strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles are common age-related lesions that are presumed to play primary pathophysiological roles in the dementia of Alzheimer’s disease (AD)(Jellinger, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Jellinger, 2009
Citations
Cites
1 retracted
Items 601–617 of 617
Mitsui, T., Kuroda, Y., & Kaji, R. (2008) · PubMed · Cited by 7
(2019) · Current clinical neurology · doi:10.1007/978-3-030-24436-1 · Cited by 7
Protein Folding, Misfolding, and Disease
Lee, J. C., Kim, J. E., Pletneva, E. V., Faraone‐Mennella, J., Gray, H. B., & Winkler, J. R. (2006) · Wiley eBooks · doi:10.1002/0470028114.ch2 · Cited by 6 · cited 2×
“Recent advances have provided insight into the detection and characterization of misfolded protein conformations and have identified critically involved intracellular nanomachines and/or multicomponent complexes (Lee et al. 2006; Lyubchenko et al. 2006; Rubinsztein 2006).”
BackgroundLes encéphalomyopathies mitochondriales
Mikol, J., & Polivka, M. (2005) · Annales de Pathologie · doi:10.1016/s0242-6498(05)80132-4 · Cited by 6 · cited 1×
“…8,344 in the mtRNA-Lys gene or rare mutations in tRNAser gene, or MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), caused by a mutation of nucleotide 3,243 in the mtRNA Leu/UUR gene (for review see (Mikol and Polivka 2005; Warner and Hammans 2008).”
BackgroundMolecular Mechanisms of Neuronal Death
Ribé, E. M., Heidt, L., Beaubier, N. T., & Troy, C. M. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_2 · Cited by 6
Apoptotic and Oxidative Indicators in Alzheimer’s Disease
Raina, A. K., Sayre, L. M., Atwood, C., Rottkamp, C. A., Hochman, A., Zhu, X., Obrenovich, M. E., Shimohama, S., Nunomura, A., Takeda, A., et al. (2002) · Neuromethods · doi:10.1385/1-59259-188-4:225 · Cited by 6 · cited 1×
“This phenomenon of apoptotic avoidance termed abortive apoptosis or abortosis, may represent an exit from the caspase-induced death program (Raina et al. 2002).”
BackgroundSynuclein Structure and Function in Parkinson’s Disease
Eliezer, D. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_7 · Cited by 4 · cited 3×
“Many proteins associated with NDDs are intrinsically disordered under physiological conditions (Eliezer 2009b; Uversky 2009).”
BackgroundWong, E. S. P., Tan, J. M. M., & Lim, K. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_3 · Cited by 4 · cited 1×
“In this way, the cell could preserve its proteasomal functions over prolonged periods of stress and recover thereafter (Wong et al. 2009).”
BackgroundStructural Disorder and Its Connection with Misfolding Diseases
Csizmók, V., & Tompa, P. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_1 · Cited by 4 · cited 3×
“…during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005;…”
BackgroundOxidative stress and nitrosative stress in Parkinson's disease
Tsang, A. H. K., & Chung, K. K. K. (2009) · Biochimica et Biophysica Acta · Cited by 4
Iron and its Role in Neurodegenerative Diseases
Ward, R. J., & Crichton, R. R. (2006) · Wiley eBooks · doi:10.1002/0470028114.ch10 · Cited by 3 · cited 3×
“ruption in metal homeostasis and the increased oxidative damage; brain ferritin iron being a risk factor for age at onset of NDDs (Bartzokis et al. 2004; Ward and Crichton 2006).”
BackgroundHuber, A., Bürkle, A., & Münch, G. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_6 · Cited by 3 · cited 2×
“…imbalance is met by a series of complex reactions (mitochondrial dysfunction, impaired synaptic transmission, disruption of membrane integrity, impaired axonal transport, etc.) to establish a disease-related homeostasis balance (Crouch et al. 2008; Huber et al. 2007; Nunomura et al. 2006, 2009).”
BackgroundThe ubiquitin proteasome system in human disease
Layfield, R., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.002 · Cited by 2 · cited 1×
“The UPS, the major non-lysosomal system for regulating protein turnover, and the autophagy–lysosome pathway (ALP) are the two most important mechanisms for regulating protein handling (Layfield and Mayer 2008; Thompson et al. 2008; van Tijn et al. 2008).”
BackgroundProtein Misfolding and Axonal Protection in Neurodegenerative Diseases
Inoue, H., Kondo, T., Lin, L., Mi, S., Isacson, O., & Takahashi, R. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_4 · Cited by 2 · cited 4×
“In addition to showing common morphological and chemical features, the inclusion bodies co-localize with several other proteins that are not structural elements of abnormal fibers, but are binding to them, including various hallmark chaperones and components of the UPS protein implicated in cellular responses, associa…”
BackgroundInfluentialRecent progress and future direction of neurodegenerative disease research
Takahashi, R. (2008) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.48.903 · Cited by 2 · cited 1×
“3) (Cairns et al. 2004; Fontaine and Brown 2009; Forman et al. 2004; Soto and Estrada 2008; Takahashi 2008).”
BackgroundNext steps for pluripotent iPS cells
Baas, T. (2009) · Science-Business eXchange · doi:10.1038/scibx.2009.1300 · Cited by 1
Osherovich, L. Z. (2009) · Science-Business eXchange · doi:10.1038/scibx.2009.300 · Cited by 1 · cited 1×
“This extracellular fragment of APP, and death receptor G (DRG) activating a widespread caspase-dependent self-destructing process (via caspase-6), might be a major culprit behind AD (Nikolaev et al. 2009; Osherovich 2009).”
Background
Research works printed but not linked: 2
- Mattson P, Bazan NG (2006) Apoptosis and necrosis. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 603–615
- Morfini GA, Stenoien DL, Brady ST (2006) Axonal transport. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 485–501
Cited by
KEGG: integrating viruses and cellular organisms
Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M., & Tanabe, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa970 · Cited by 3,436
Microalgae for High-Value Products Towards Human Health and Nutrition
Barkia, I., Saari, N., & Manning, S. R. (2019) · Marine Drugs · doi:10.3390/md17050304 · Cited by 719
“This is supported by the overproduction of ROS in early-stage patients that results in cleaving and misfolding of the amyloid precursor protein to amyloid beta-peptide (Aβ), which induces mitochondrial dysfunction and facilitates the formation of amyloid plaques [230].”
BackgroundPhotoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., Abd El-Aziz, M. M., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 631
“Integrating diverse cellular stresses Some themes, such as increased RONS and bioenergetic dysfunction, recur in the PR cell-death mechanisms discussed above, but how do the different mechanisms converge on a final common death pathway? Similar mechanistic themes have been identified for neurodegenerative disorders th…”
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“1 Algorithm for classification of neurodegenerative diseases with protein deposits (proteinopathies) (from [1]).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Jellinger, K. A.
- Corresponding author
- Jellinger, Kurt A.
- ORCID
- Jellinger, Kurt A.
- Venue
- Journal of Neural Transmission
- Published
- 2009-06-05
- Volume
- 116
- Issue
- 9
- Pages
- 1111-1162
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2091026347
- Cited by
- 274
- References
- 618
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 27 · 2012: 23
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurodegeneration, proteinopathies, protein misfolding, ubiquitin-proteasome system, autophagy, oxidative stress, mitochondrial dysfunction, Golgi apparatus, molecular chaperones, neurotrophins, neuroinflammation, programmed cell death, amyloid-beta, tau protein, alpha-synuclein, TDP-43, preclinical diagnosis, common pathogenic mechanisms, neurodegenerative disease classification
- MeSH terms
- Free Radicals, Humans, Models, Biological, Mutation, Nerve Tissue Proteins, Protein Folding, Oxidative Stress, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.